Bioceres Crop Solutions Corp. (BIOX) stock
Close on Nov 11, 2026Market cap $14.85MP/E –Yield –
Bioceres Crop Solutions statistics
82 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- –
- Last ex-dividend date
- No dividends
- Fundamentals through
- Jun 30, 2026
- Share price as of
- Nov 11, 2026
Valuation ratiosIndustry
- P/OCF Ratio
- 0.22
- 13.11
Enterprise valuationIndustry
- EV / Sales
- 0.56
- 2.65
- EV / FCF
- 2.07
- 22.15
Share statisticsIndustry
- Shares Change (YoY)
- 0.66%
- 10.9%
- Float
- 17M
- 49M
- Shares Held by Insiders
- 73.3%
- 11.6%
- Shares Held by Institutions
- 13.2%
- 56.4%
Short sellingIndustry
- Short Interest
- 458,064
- –
- Short Interest Change
- -46.3%
- -0.76%
- Short % of Float
- 2.69%
- 9.06%
- Short % of Shares Outstanding
- 0.72%
- 6.38%
- Days to Cover
- 1.71
- 5.16
Stock price statisticsIndustry
- 52-Week High
- $2.03
- –
- 52-Week Low
- $0.19
- –
- 20-Day Moving Average
- $0.24
- –
- 50-Day Moving Average
- $0.32
- –
- 200-Day Moving Average
- $0.43
- –
- Average True Range (14)
- $0.04
- –
- Price Change (1 Week)
- -8.17%
- -0.50%
- Price Change (1 Month)
- -28.4%
- -0.33%
- Price Change (3 Months)
- -45.9%
- -17.2%
- Price Change (6 Months)
- -43.1%
- -20.1%
- Price Change (YTD)
- -82.2%
- -20.1%
- Price Change (1 Year)
- -86.6%
- -19.3%
- Price Change (3 Years)
- -97.7%
- -23.4%
- Price Change (5 Years)
- -98.4%
- -76.4%
- Average Volume (10 Days)
- 197,018
- –
- Average Volume (20 Days)
- 247,510
- –
- Average Volume (90 Days)
- 260,872
- –
- Relative Volume
- 0.36
- 0.73
- Relative Strength Index (14)
- 43.3
- 47.6
- Volatility (1 Year)
- 99.5%
- 80.2%
- Beta (5 Years)
- 0.75
- 1.07
MarginsIndustry
- Pretax Margin
- -31.7%
- -12.1%
- EBITDA Margin
- -9.82%
- -25.0%
- FCF Margin
- 27.3%
- -9.55%
Returns on capitalIndustry
- Return on Invested Capital (ROIC)
- -7.44%
- -34.0%
- Return on Capital Employed (ROCE)
- -13.2%
- -37.7%
Financial positionIndustry
- Current Ratio
- 0.80
- 3.30
- Quick Ratio
- 0.40
- 2.37
- Debt / Equity
- 10.01
- 0.49
- Debt / FCF
- 1.65
- 4.62
- Interest Coverage
- -0.59
- -6.27
GrowthIndustry
- Revenue Growth (YoY)
- -17.7%
- 7.01%
- FCF Growth (YoY)
- 45.2%
- 6.85%
- Revenue Growth (3Y CAGR)
- -17.2%
- 2.25%
- Revenue Growth (5Y CAGR)
- 2.61%
- 6.41%
EfficiencyIndustry
- Asset Turnover
- 0.39
- 0.40
- Inventory Turnover
- 2.31
- 2.68
- Revenue Per Employee
- $423.98K
- $426.63K
- Employee Count
- 562
- 75
- WACC
- 11.4%
- 10.1%
Income statement (TTM)Industry
- Pretax Income
- -$75.48M
- -$13.50M
Balance sheetIndustry
- Net Cash (Debt)
- -$96.00M
- $16.31M
- Net Cash Per Share
- -$1.50
- $0.70
- Equity (Book Value)
- $10.72M
- $53.12M
- Book Value Per Share
- $0.17
- $1.49
- Tangible Book Value
- -$92.49M
- $26.11M
- Working Capital
- -$54.93M
- $77.59M
Cash flow (TTM)Industry
- Capital Expenditures
- -$1.05M
- -$939.00K
- FCF Per Share
- $1.02
- -$0.42
Dividends and yieldsIndustry
- FCF Yield
- 437.4%
- -8.81%
Taxes and interestIndustry
- Interest Expense
- $39.92M
- $2.98M
- Income Tax
- $6.96M
- $79.50K
Scores and fair valueIndustry
- Altman Z-Score
- 0.23
- 0.28
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | BIOX | S&P 500 | Difference | BIOX per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -29.1% | -2.4% | −26.7 pts | ||
| 3 months | -35.1% | -1.2% | −34.0 pts | ||
| Year to date | -82.2% | +12.3% | −94.5 pts | ||
| 1 year | -87.9% | +12.4% | −100.4 pts | ||
| 3 years | -97.7% | +78.8% | −176.6 pts | -71.8% | +21.4% |
| 5 years | -98.3% | +75.2% | −173.5 pts | -55.9% | +11.9% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
0M BIOX shares were sold short on Oct 30, 2026, down 46.3% from the previous report, or 2.69% of the shares available to trade. At recent volumes it would take 1.7 days to buy them back. Over the last 20 sessions, 45.9% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 458,064 | -46.3% | 268,438 | 1.7 |
| Oct 15, 2026 | 852,535 | -7.7% | 129,497 | 6.6 |
| Sep 30, 2026 | 923,789 | +104.0% | 287,044 | 3.2 |
| Sep 15, 2026 | 452,852 | +38.2% | 237,538 | 1.9 |
| Aug 31, 2026 | 327,738 | -64.1% | 718,829 | 1.0 |
| Aug 14, 2026 | 913,482 | +26.0% | 187,188 | 4.9 |
| Jul 31, 2026 | 724,871 | -31.8% | 84,397 | 8.6 |
| Jul 15, 2026 | 1,062,614 | +15.5% | 136,136 | 7.8 |
| Jun 30, 2026 | 920,213 | +7.1% | 328,894 | 2.8 |
| Jun 15, 2026 | 859,203 | -1.5% | 238,362 | 3.6 |
| May 29, 2026 | 872,016 | +0.7% | 282,488 | 3.1 |
| May 15, 2026 | 866,373 | +18.9% | 322,149 | 2.7 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?